SCHEMBL9737759

SCHEMBL9737759

CC(C)n1nc(C(OC2CCCCC2)OC2CCCCC2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.33
PPARG P37231 3/20 0.32
SLC33A1 O00400 4/20 0.31
AGTR1 P30556 3/20 0.31
AGTR2 P50052 2/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
MLNR O43193 1/20 0.30
NR1I2 O75469 1/20 0.30
USP2 O75604 1/20 0.30
ESR1 P03372 1/20 0.30
NR3C1 P04150 1/20 0.30
TP53 P04637 1/20 0.30
PGR P06401 1/20 0.30
ADRB2 P07550 1/20 0.30
CHRM2 P08172 1/20 0.30
ADRB1 P08588 1/20 0.30
CYP3A4 P08684 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9739948 0.87 SLC33A1 (0.33) SLC33A1
SCHEMBL9738067 0.87 AGTR1 (0.39) PPARGSLC33A1AGTR1AGTR2
SCHEMBL9738485 0.86 SLC33A1 (0.33) PPARGSLC33A1AGTR1AGTR2
SCHEMBL9739337 0.85 AGTR1 (0.45) PPARGAGTR1AGTR2
SCHEMBL9738273 0.85 AGTR1 (0.33) PPARGSLC33A1AGTR1AGTR2
SCHEMBL9739338 0.85 AGTR1 (0.33) AGTR1AGTR2
SCHEMBL9739129 0.84 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9738411 0.84 TRPV1 (0.32) TRPV1PPARGSLC33A1AGTR1AGTR2
SCHEMBL9738526 0.84 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9738817 0.84 CNR2 (0.34) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed